Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial.

Author: AusiliE, Di RoccoC, FocarelliB, FundaròC, GenoveseO, PantanellaA, RendeliC, TabaccoF

Paper Details 
Original Abstract of the Article :
AIM: To compare the therapeutic effectiveness and tolerability of low daily doses of polyethylene glycol 4000 vs. lactulose in the treatment of neurogenic constipation in children with myelomeningocele. METHODS: Sixty-seven children with chronic neurogenic constipation were randomized allocated to ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1365-2036.2006.02872.x

データ提供:米国国立医学図書館(NLM)

Finding Relief for Neurogenic Constipation in Children: Polyethylene Glycol vs. Lactulose

Neurogenic constipation, a condition often affecting children with myelomeningocele, can be a significant challenge. This study compares the effectiveness and tolerability of two commonly used treatments, polyethylene glycol 4000 and lactulose, in alleviating constipation in this population. The researchers conducted a randomized controlled trial, finding that polyethylene glycol 4000 was significantly more effective in improving bowel frequency and reducing constipation symptoms compared to lactulose.

Polyethylene Glycol 4000: A Promising Solution for Neurogenic Constipation

The study revealed that polyethylene glycol 4000, administered at a dose of 0.50 g/kg daily, was significantly more successful in treating neurogenic constipation compared to lactulose. Nearly half of the children receiving polyethylene glycol 4000 experienced complete remission of their constipation symptoms, compared to only 22% in the lactulose group. Furthermore, polyethylene glycol 4000 was associated with a higher bowel frequency and a reduction in encopresis, a condition characterized by fecal incontinence.

Addressing Constipation in Children with Myelomeningocele: A Focus on Safety

This research offers valuable insights into the treatment of neurogenic constipation in children with myelomeningocele. While polyethylene glycol 4000 appears to be a more effective option, it's important to remember that every child is unique, and individual responses to treatment can vary. It's crucial to consult with a healthcare professional to determine the most appropriate treatment plan for each child.

Dr.Camel's Conclusion

Like a camel navigating a winding desert path, finding the right treatment for neurogenic constipation can feel like a journey with unexpected twists and turns. This research sheds light on a potential solution, suggesting that polyethylene glycol 4000 may provide a smoother and more effective path to relief. Remember, every journey requires careful planning and a personalized approach, ensuring that the path chosen is the safest and most effective for reaching the desired destination.

Date :
  1. Date Completed 2006-06-29
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

16611288

DOI: Digital Object Identifier

10.1111/j.1365-2036.2006.02872.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.